Liquid hydrogen patch
The liquid hydrogen patch combined with the Ni-CNH catalyst and the antibacterial and anti-inflammatory drug layer solves the problem that traditional bandages are difficult to create a hydrogen environment for a long time, and achieves efficient antibacterial effects and wound healing.
Patent Information
- Application Number
- CN202410962897.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-18
- Publication Date
- 2024-11-08
AI Technical Summary
Traditional Band-Aids are difficult to create a hydrogen environment for a long time, and cannot effectively prevent wound infection and speed up wound healing.
The Ni-CNH catalyst is used to prepare a polyacrylamide hydrogel-supported nickel element through cross-linking reaction, combining an antibacterial and anti-inflammatory drug layer and extruded hydrazine hydrate capsule to catalyze the dehydrogenation reaction of hydrazine hydrate to produce hydrogen, forming liquid hydrogen stickers.
It has achieved a long-term creation of a hydrogen environment, significantly improved the antibacterial effect of Band-Aids, prevented wound infection, and accelerated the wound healing process.
Smart Images

Figure CN118904344A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of hydrogen medicine, and in particular to a liquid hydrogen patch. Background Art
[0002] In the prior art, the journal Nature Medicine published a paper titled "Hydrogen Removes Free Radicals through Selective Antioxidant Effects" by the Hydrogen Molecular Medicine Research Center of Japan Medical University, which confirmed that hydrogen, as the smallest molecule in nature, can easily diffuse into any organ, tissue, cell, mitochondria and cell nucleus of the body, and achieves the ideal antioxidant effect by selectively removing malignant free radicals. A global upsurge in hydrogen molecular medicine research has been set off. The various biological effects of hydrogen are interrelated, not isolated. Therefore, the health value of hydrogen is the most comprehensive and complex substance discovered by humans so far.
[0003] Hydrogen has antioxidant, anti-inflammatory and anti-apoptotic effects. In terms of antioxidant, the body will produce excessive free radicals under external stimulation, which will reduce the antioxidant capacity, thereby causing an imbalance in the redox system and generating oxidative stress. Hydrogen can remove hydroxyl radicals (·OH) and peroxynitrite anions (ONOO - ), superoxide (O 2- ) and hydrogen peroxide (H2O2), effectively buffering and inhibiting oxidative stress and improving mitochondrial diseases. Other studies have shown that nanobubble technology can enhance the antioxidant activity of hydrogen water and effectively remove cytotoxic reactive oxygen species such as hydroxyl free radicals.
[0004] In terms of anti-inflammatory effects, hydrogen can inhibit the expression of pro-inflammatory factors, induce downregulation of inflammatory cytokines such as interleukin-6, intercellular adhesion molecules and some phosphorylated signaling molecules, and oral administration of hydrogen water can prevent chronic allograft nephropathy in rats. Rats treated with hydrogen water can reduce the local production of inflammatory markers and inflammatory cell infiltration, and inhibit the activation of inflammatory signaling pathways. In terms of anti-apoptosis, hydrogen can reduce the activation levels of ASK-1 and JNK, increase the Bcl-2 / Bax ratio, and is used to treat ischemia-reperfusion injury in rat skin tissue.
[0005] As a liquid phase hydrogen storage material, hydrazine hydrate can quickly produce hydrogen through catalytic conversion under mild conditions, and the only byproduct is environmentally friendly nitrogen. It is a very promising hydrogen storage material. In the presence of a catalyst, it can continuously and efficiently decompose and release hydrogen at room temperature.
[0006] Catalysts for the dehydrogenation reaction of hydrazine hydrate can be divided into single metal and multi-metal systems according to the types of metals contained. Among single metal catalysts, precious metals have better catalytic activity; non-precious metals have low cost and abundant resources, but their activity is generally weak; single metal catalysts are easy to agglomerate and oxidize, have low catalytic activity, and unstable performance; the activity of multi-metal systems has generally improved, and catalysts containing precious metals have higher activity, but the cost of using precious metals is relatively high, and they are not suitable for the preparation of hydrogen. Summary of the invention
[0007] In view of this, the purpose of the present invention is to provide a liquid hydrogen bandage. When used, the liquid hydrogen bandage provided by the present invention can create a hydrogen environment for a long time, which can make the bandage have an antibacterial effect, make up for the shortcomings of traditional bandages, prevent wound infection, and accelerate wound healing.
[0008] In order to achieve the above object, the present invention provides the following technical solutions:
[0009] One of the technical solutions of the present invention is a method for preparing a Ni-CNH catalyst, comprising the following steps:
[0010] Using acrylamide and acrylic acid as raw materials, adding a cross-linking agent to carry out a cross-linking reaction to prepare polyacrylamide hydrogel;
[0011] After the nickel element is loaded in the polyacrylamide hydrogel, heat treatment is performed to obtain a Ni-CNH catalyst.
[0012] The second technical solution of the present invention is a Ni-CNH catalyst prepared by the above preparation method.
[0013] A third technical solution of the present invention is an application of the above-mentioned Ni-CNH catalyst in catalyzing the dehydrogenation reaction of hydrazine hydrate.
[0014] The fourth technical solution of the present invention is a liquid hydrogen patch, comprising an antibacterial and anti-inflammatory drug layer 1, a catalyst layer 2 and an extrudable hydrazine hydrate capsule 3; the antibacterial and anti-inflammatory drug layer 1 is located on the hydrogen patch body, the catalyst layer 2 is located on one side of the antibacterial and anti-inflammatory drug layer 1, and the extrudable hydrazine hydrate capsule 3 is located on the catalyst layer 2; the catalyst layer 2 includes the Ni-CNH catalyst.
[0015] The present invention discloses the following technical effects:
[0016] The invention adopts a gel method for synthesizing the catalyst, which is easy to operate and industrially applicable. The preparation method is simple and easy to industrialize.
[0017] The catalyst provided by the present invention has high activity and selectivity. When the catalyst is used for hydrazine hydrate dehydrogenation reaction, the dehydrogenation conversion rate and selectivity can reach 100%, and the TOF value of the reaction is greater than 664.9h-1 .
[0018] Compared with traditional band-aids, the liquid hydrogen band-aid provided by the present invention can create a hydrogen environment for a long time when used, so that the band-aid can have an antibacterial effect, make up for the shortcomings of traditional band-aids, prevent wound infection, and accelerate wound healing. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0020] Figure 1 It is a schematic diagram of the structure of the liquid hydrogen patch in the present invention, wherein 1 is an antibacterial and anti-inflammatory drug layer, 2 is a catalyst layer, and 3 is an extrudable hydrazine hydrate capsule. DETAILED DESCRIPTION
[0021] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as limiting the present invention, but should be understood as a more detailed description of certain aspects, features, and embodiments of the present invention.
[0022] It should be understood that the terms described in the present invention are only for describing a particular embodiment and are not intended to limit the present invention. In addition, for the numerical range in the present invention, it should be understood that each intermediate value between the upper and lower limits of the scope is also specifically disclosed. The intermediate value in any stated value or stated range, and each smaller range between any other stated value or intermediate value in the described range is also included in the present invention. The upper and lower limits of these smaller ranges can be independently included or excluded in the scope.
[0023] Unless otherwise indicated, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art. Although the present invention describes only preferred methods and materials, any methods and materials similar or equivalent to those described herein may also be used in the implementation or testing of the present invention. All documents mentioned in this specification are incorporated by reference to disclose and describe the methods and / or materials associated with the documents. In the event of a conflict with any incorporated document, the content of this specification shall prevail.
[0024] It will be apparent to those skilled in the art that various modifications and variations may be made to the specific embodiments of the present invention description without departing from the scope or spirit of the present invention. Other embodiments derived from the present invention description will be apparent to the skilled artisan. The present invention description and examples are exemplary only.
[0025] The words “include,” “including,” “have,” “contain,” etc. used in this document are open-ended terms, meaning including but not limited to.
[0026] The present invention provides a method for preparing a Ni-CNH catalyst, comprising the following steps:
[0027] Using acrylamide and acrylic acid as raw materials, adding a cross-linking agent to carry out a cross-linking reaction to prepare polyacrylamide hydrogel;
[0028] After the nickel element is loaded in the polyacrylamide hydrogel, heat treatment is performed to obtain a Ni-CNH catalyst.
[0029] In some embodiments, the cross-linking agent is methylene acrylamide; the mass volume ratio of the acrylamide, acrylic acid and the cross-linking agent is 2.16g:0.66mL:0.01g.
[0030] In some embodiments, when the cross-linking reaction is carried out, the reaction system further includes an initiator; the mass volume ratio of the initiator to the acrylic acid is 0.0216 g:0.66 mL.
[0031] In some embodiments, the initiator is ammonium persulfate.
[0032] In some embodiments, the cross-linking reaction is carried out at a temperature of 80° C. and for 15 minutes.
[0033] In some embodiments, the specific steps of loading nickel element in the polyacrylamide hydrogel are: after mixing the polyacrylamide hydrogel, nickel salt and water, standing, and drying after the polyacrylamide hydrogel completely absorbs the nickel salt solution.
[0034] In some embodiments, the ratio of the amount of nickel element to water in the polyacrylamide hydrogel and nickel salt is 0.4 g:1.5 mmol:5 mL.
[0035] In some embodiments, the nickel salt is hydrated nickel nitrate.
[0036] In some embodiments, the heat treatment is performed at a temperature of 280° C. for 4 hours; and the heat treatment is performed under the protection of an inert atmosphere.
[0037] In some embodiments, the inert atmosphere is a N2 atmosphere.
[0038] The present invention also provides a Ni-CNH catalyst prepared by the preparation method.
[0039] The present invention also provides application of the Ni-CNH catalyst in catalyzing a dehydrogenation reaction of hydrazine hydrate.
[0040] The Ni-CNH catalyst provided by the present invention has high activity and selectivity. When the catalyst is used for hydrazine hydrate dehydrogenation reaction, the dehydrogenation conversion rate and selectivity can reach 100%, and the TOF value of the reaction is greater than 664.9h -1 .
[0041] The present invention also provides a liquid hydrogen patch, comprising an antibacterial and anti-inflammatory drug layer 1, a catalyst layer 2 and an extrudable hydrazine hydrate capsule 3; the antibacterial and anti-inflammatory drug layer 1 is located on the hydrogen patch body, the catalyst layer 2 is located on one side of the antibacterial and anti-inflammatory drug layer 1, and the extrudable hydrazine hydrate capsule 3 is located on the catalyst layer 2; the catalyst layer 2 comprises the Ni-CNH catalyst.
[0042] In some embodiments, the catalyst layer contains a Ni-CNH catalyst; the hydrazine hydrate capsule contains hydrazine hydrate; the mass ratio of the Ni-CNH catalyst to hydrazine hydrate is 1:(12-20); the concentration of the hydrazine hydrate is 0.5-3.0 mol / L; and the volume of the hydrazine hydrate is 0.02 mL.
[0043] In the present invention, the main body of the hydrogen bandage is a medical polyurethane film, which is also called a PU film. It has the characteristics of good elasticity and high lightness. It not only has excellent high waterproofness but also has good moisture permeability, so that the bandage can have a waterproof effect and can also discharge human sweat when used. In addition, the PU film is environmentally friendly, non-toxic, recyclable and decomposable, and can be perfectly suitable for use as a base material for bandages.
[0044] In the present invention, the drug in the antibacterial and anti-inflammatory drug layer is benzalkonium chloride, which is a cationic surfactant with high efficiency and broad spectrum disinfection and sterilization effects. It is mainly used for disinfection of skin, mucous membranes and wounds, and can change the permeability of bacterial cytoplasmic membranes, causing bacterial cytoplasmic substances to extravasate, thereby hindering their metabolism and playing a killing role.
[0045] In the present invention, the method of using the liquid hydrogen patch is as follows: when a wound occurs, the antibacterial and anti-inflammatory drug layer is covered on the wound, and the extrudable hydrazine hydrate capsule is squeezed to rupture it. At this time, the Ni-CNH catalyst catalyzes the dehydrogenation reaction of hydrazine hydrate to produce hydrogen.
[0046] In order to better understand the present invention, the content of the present invention is further explained below in conjunction with the embodiments, but the content of the present invention is not limited to the following embodiments.
[0047] The test reagents used in the examples are all conventional biochemical reagents unless otherwise specified; the experimental methods are all conventional methods unless otherwise specified.
[0048] If the specific conditions are not specified in the examples, the conditions are carried out according to conventional conditions or the conditions recommended by the manufacturer. If the manufacturer is not specified in the reagents or instruments used, they are all conventional products that can be purchased commercially. It should be noted that, in the absence of conflict, the features in the embodiments of the present invention and in the embodiments can be combined with each other.
[0049] Example 1
[0050] This embodiment provides a Ni-CNH catalyst, and the preparation method is as follows:
[0051] (1) Weigh 2.16 g of acrylamide and 0.01 g of methylene acrylamide into a beaker, add 10 mL of distilled water, and stir;
[0052] (2) adding 0.0216 g of ammonium persulfate and 0.66 mL of acrylic acid to the liquid being stirred in (1), and stirring for 10 min;
[0053] (3) Pour the stirred liquid in (2) into a culture dish and heat to 80°C for 15 min. After the insulation is completed, take out the polyacrylamide hydrogel, put it into a 500 mL beaker and add 350 mL of distilled water. After standing for 24 h, take it out and cut it into pieces, and dry it at 80°C for 12 h.
[0054] (4) Take 0.4 g of the dried hydrogel in (3) and 1.5 mmol of hydrated nickel nitrate and add them into a small beaker, then add 5 mL of distilled water. After the hydrogel has completely absorbed the nickel nitrate solution, dry it at 80° C. to obtain a precursor;
[0055] (5) The precursor in (4) was heated to 280 °C under a N2 atmosphere and kept at this temperature for 4 h to obtain a Ni-CNH catalyst.
[0056] After 1g of Ni-CNH catalyst obtained in this example and 12g of hydrazine hydrate (concentration of 3.0 mol / L) were mixed evenly, the mixture was reacted at 25°C (about 25°C) for 20 seconds to obtain hydrogen gas. The dehydrogenation conversion rate and selectivity were measured. The results showed that the dehydrogenation conversion rate and selectivity of hydrazine hydrate could reach 100%, and the TOF value of the reaction was greater than 664.9h -1 .
[0057] Example 2
[0058] This embodiment provides a liquid hydrogen sticker, the structural diagram of which is as follows Figure 1 shown.
[0059] In this embodiment, the solid hydrogen bandage is composed of a transparent porous permeable layer (i.e., the bandage body), an antibacterial and anti-inflammatory drug layer, a catalyst layer, and an extrudable hydrazine hydrate capsule.
[0060] Among them, the transparent porous permeable layer: a 20mm×65mm PU film is used as the base material, and medical maleic glue is evenly applied on the PU film to form an adhesive layer;
[0061] Antibacterial and anti-inflammatory drug layer: The drug layer is made of cotton cloth, and 0.05% benzalkonium chloride is applied on its surface;
[0062] Catalyst layer: 10 mg of the Ni-CNH catalyst obtained in Example 1 was spread on a 10 mm × 20 mm sponge layer;
[0063] Extrudable hydrazine hydrate capsule: The concentration of hydrazine hydrate in the extrudable hydrazine hydrate capsule is 3 mol / L, a total of 0.02 mL.
[0064] Comparative Example 1
[0065] This comparative example provides a band-aid, which is different from Example 2 only in that the catalyst layer and the extrudable hydrazine hydrate capsule are omitted, and the other parts are the same as Example 2.
[0066] The liquid hydrogen band-aid in Example 2 and the band-aid in Comparative Example 1 were tested for their antibacterial effects using the test method in 2.1. Antibacterial (inhibitory) test in the 2002 edition of the Technical Specifications for Disinfection. The two groups of band-aids were sterilized by ultraviolet irradiation and inoculated with 8.0×10 4 The Escherichia coli and Staphylococcus aureus with CFU / piece were cultured at 25°C, and the bacterial count was tested after 30 minutes (during the culture, the extrudable hydrazine hydrate capsule in the liquid band-aid in Example 2 was squeezed to react with the catalyst to produce hydrogen). The test results are shown in Table 1.
[0067] Table 1 Antibacterial test results of the band-aid in Example 2 and Comparative Example 1
[0068] Staphylococcus aureus (CPU / chip) Escherichia coli inhibition zone (CPU / piece) Example 2 <![CDATA[1.21×10 3 ]]> <![CDATA[1.14×10 3 ]]> Comparative Example 1 <![CDATA[5.42×10 3 ]]> <![CDATA[6.27×10 3 ]]>
[0069] It can be seen from Table 1 that the antibacterial effect of the liquid hydrogen bandage provided by the present invention is significantly better than that of ordinary bandages. Therefore, it can be seen that the liquid hydrogen bandage provided by the present invention has better antibacterial ability and is conducive to wound healing.
[0070] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A method for preparing a Ni-CNH catalyst, characterized in that: The following steps are involved: Using acrylamide and acrylic acid as raw materials, adding a cross-linking agent to carry out a cross-linking reaction to prepare polyacrylamide hydrogel; After the nickel element is loaded in the polyacrylamide hydrogel, heat treatment is performed to obtain a Ni-CNH catalyst.
2. The method for preparing the Ni-CNH catalyst according to claim 1, characterized in that: The cross-linking agent is methylene acrylamide; the mass volume ratio of the acrylamide, acrylic acid and the cross-linking agent is 2.16g:0.66mL:0.01g.
3. The method for preparing the Ni-CNH catalyst according to claim 1, characterized in that: When the cross-linking reaction is carried out, the reaction system also includes an initiator; the mass volume ratio of the initiator to the acrylic acid is 0.0216g:0.66mL.
4. The method for preparing the Ni-CNH catalyst according to claim 3, characterized in that: The initiator is ammonium persulfate.
5. The method for preparing the Ni-CNH catalyst according to claim 1, characterized in that: The temperature of the cross-linking reaction is 80° C. and the time is 15 minutes.
6. The method for preparing the Ni-CNH catalyst according to claim 1, characterized in that: The specific steps of loading nickel element in the polyacrylamide hydrogel are as follows: after mixing the polyacrylamide hydrogel, nickel salt and water, the mixture is allowed to stand, and after the polyacrylamide hydrogel completely absorbs the nickel salt solution, the mixture is dried.
7. The method for preparing the Ni-CNH catalyst according to claim 1, characterized in that: The heat treatment temperature is 280° C. and the time is 4 hours; the heat treatment is carried out under the protection of an inert atmosphere.
8. A Ni-CNH catalyst prepared by the preparation method according to any one of claims 1 to 7.
9. Use of the Ni-CNH catalyst according to claim 8 in catalyzing the dehydrogenation reaction of hydrazine hydrate.
10. A liquid hydrogen patch, characterized in that: The invention comprises an antibacterial and anti-inflammatory drug layer (1), a catalyst layer (2) and an extrudable hydrazine hydrate capsule (3); the antibacterial and anti-inflammatory drug layer (1) is located on the hydrogen-adhesive body, the catalyst layer (2) is located on one side of the antibacterial and anti-inflammatory drug layer (1), and the extrudable hydrazine hydrate capsule (3) is located on the catalyst layer (2); the catalyst layer (2) comprises the Ni-CNH catalyst according to claim 8.
Citation Information
Patent Citations
Application of nickel-based catalyst in preparation of hydrogen through hydrazine decomposition
CN105214673A
Nitrogen-doped carbon-loaded monoatomic metal composite catalyst, and preparation method and application thereof
CN110247070A
Hydrogen slow-release agent containing ammonia borane and application thereof
CN111153382A
Preparation method of copper-iron double-metal doped acrylamide hydrogel material
CN117430763A
Micro-nano magnesium hydride antibacterial and anti-inflammatory wound dressing
CN209392452U
